548 related articles for article (PubMed ID: 20431066)
1. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
Harder C; Lau P; Meng A; Whitman SC; McPherson R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
Zhou H; Li Z; Silver DL; Jiang XC
Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
[TBL] [Abstract][Full Text] [Related]
5. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice.
Brundert M; Ewert A; Heeren J; Behrendt B; Ramakrishnan R; Greten H; Merkel M; Rinninger F
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):143-8. PubMed ID: 15528479
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Phospholipid Transfer Protein-Mediated High-Density Lipoprotein Maturation Reduces Scavenger Receptor BI Deficiency-Driven Atherosclerosis Susceptibility Despite Unexpected Metabolic Complications.
Hoekstra M; van der Sluis RJ; Hildebrand RB; Lammers B; Zhao Y; Praticò D; van Berkel TJC; Rensen PCN; Kooijman S; Jauhiainen M; van Eck M
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):611-623. PubMed ID: 31941380
[TBL] [Abstract][Full Text] [Related]
9. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
Korporaal SJ; Meurs I; Hauer AD; Hildebrand RB; Hoekstra M; Cate HT; Praticò D; Akkerman JW; Van Berkel TJ; Kuiper J; Van Eck M
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):34-42. PubMed ID: 21051668
[TBL] [Abstract][Full Text] [Related]
11. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
12. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
13. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
14. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues.
Huby T; Doucet C; Dachet C; Ouzilleau B; Ueda Y; Afzal V; Rubin E; Chapman MJ; Lesnik P
J Clin Invest; 2006 Oct; 116(10):2767-76. PubMed ID: 16964311
[TBL] [Abstract][Full Text] [Related]
15. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
Hirano K; Ikegami C; Tsujii K; Zhang Z; Matsuura F; Nakagawa-Toyama Y; Koseki M; Masuda D; Maruyama T; Shimomura I; Ueda Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2422-7. PubMed ID: 16151015
[TBL] [Abstract][Full Text] [Related]
16. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.
Svensson PA; Englund MC; Snäckestrand MS; Hägg DA; Ohlsson BG; Stemme V; Mattsson-Hulten L; Thelle DS; Fagerberg B; Wiklund O; Carlsson LM; Carlsson B
BMC Cardiovasc Disord; 2005 Aug; 5():25. PubMed ID: 16122381
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells.
Covey SD; Krieger M; Wang W; Penman M; Trigatti BL
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1589-94. PubMed ID: 12829524
[TBL] [Abstract][Full Text] [Related]
18. Adrenal-specific scavenger receptor BI deficiency induces glucocorticoid insufficiency and lowers plasma very-low-density and low-density lipoprotein levels in mice.
Hoekstra M; van der Sluis RJ; Van Eck M; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e39-46. PubMed ID: 23202366
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism.
Komori H; Arai H; Kashima T; Huby T; Kita T; Ueda Y
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1298-303. PubMed ID: 18403724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
